Predictors of Adverse Outcomes in Ischemic Stroke Associated with COVID-19

Objectives. To study predictors of adverse outcomes in ischemic stroke associated with COVID-19. Materials and methods. A retrospective analysis of 173 cases of ischemic stroke and COVID-19 was carried out. Mean age was 68.64 ± 11.39 years (95% CI 66.93–70.35; M = 92, m = 34). In terms of gender, th...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience and behavioral physiology 2023-05, Vol.53 (4), p.483-488
Main Authors: Novikova, L. B., Latypova, R. F.
Format: Article
Language:English
Subjects:
Alanine transaminase
Aspartate aminotransferase
Behavioral Sciences
Bilirubin
Biomedical and Life Sciences
Biomedicine
C-reactive protein
COVID-19
Creatine
Creatine kinase
Creatinine
Erythrocytes
Hematocrit
Hemoglobin
Ischemia
Kidney diseases
L-Lactate dehydrogenase
Leukocytes (neutrophilic)
Multivariate analysis
Neurobiology
Neurosciences
Respiration
Risk factors
Statistical analysis
Stroke
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives. To study predictors of adverse outcomes in ischemic stroke associated with COVID-19. Materials and methods. A retrospective analysis of 173 cases of ischemic stroke and COVID-19 was carried out. Mean age was 68.64 ± 11.39 years (95% CI 66.93–70.35; M = 92, m = 34). In terms of gender, there was a predominance of women (64.16%). Lethal outcomes occurred in 62 (35.84%) patients. Risk factors for lethal outcome were studied by binary logistic regression. Results. Univariate analysis showed that the risk of fatal stroke was associated with the patient being in a generally severe condition and a number of other factors, which included the severity of COVID-19, acute coronary syndrome, multiple organ failure, the need for a ventilator, a history of kidney disease, pneumonia, a high NIHSS score, oxygen partial pressure, respiratory rate, the number of hospitalizations, the full blood count (erythrocytes, hemoglobin, hematocrit, leukocytes, neutrophils), the coagulogram, glucose levels, liver and kidney markers (bilirubin, aspartate aminotransferase, alanine aminotransferase, creatinine, urea), and creatine phosphokinase, lactate dehydrogenase, and C-reactive protein levels. Use of a model based on multivariate analysis allowed the probability of lethal outcome to be predicted. A regression function was obtained, which included the C-reactive protein and urea concentrations and NIHSS score. Patients with values of ≥35% were at elevated risk of death, while those with values of
ISSN:0097-0549
1573-899X
DOI:10.1007/s11055-023-01445-1